Safety study of Lisdexamfetamine Dimesylate (LDX) in ADHD
This study is completed in France, in the United Kingdom, in Belgium, .... It is testing Lisdexamfetamine Dimesylate (LDX) for ADHD.
In Belgium
Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.
This study is completed in France, in the United Kingdom, in Belgium, .... It is testing Lisdexamfetamine Dimesylate (LDX) for ADHD.
In BelgiumThis summary needs review. Please check the official study record and contact the research team for details.
In BelgiumThis summary needs review. Please check the official study record and contact the research team for details.
In BelgiumThis study is active but not recruiting in Belgium. It is testing screening and Referral Practices for depression.
Remote / onlineThis summary needs review. Please check the official study record and contact the research team for details.
In BelgiumThis summary needs review. Please check the official study record and contact the research team for details.
In BelgiumThis study is completed in France and in Belgium. 649 for ADHD.
In BelgiumThis study exists to understand how questionnaires and follow-up reports holds up over time after the earliest research stage. Researchers are trying to understand whether questionnaires and follow-up reports can improve attention, thinking, or day-to-day functioning.
In BelgiumThis summary needs review. Please check the official study record and contact the research team for details.
In BelgiumThis summary needs review. Please check the official study record and contact the research team for details.
In BelgiumThis summary needs review. Please check the official study record and contact the research team for details.
In BelgiumThis study is completed in the United States, in France, in Belgium, .... It is testing 3 Fixed Doses of Intranasal Esketamine for depression.
In BelgiumHopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.